Viral miRNA-mediated activation of hyaluronan production as a drug target against COVID-19

被引：3
|
作者：
Yang, Shuai [1 ,2 ,3 ,4 ]
Chen, Lu [1 ,2 ,3 ,4 ]
Tong, Ying [1 ,2 ,3 ,4 ]
Yu, Wenqiang [1 ,2 ,3 ,4 ]
机构：
[1] Fudan Univ, Inst Biomed Sci, Lab RNA Epigenet, Shanghai 200040, Peoples R China
[2] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 200040, Peoples R China
[3] Fudan Univ, Huashan Hosp, Canc Metastasis Inst, Dept Gen Surg,Shanghai Med Coll, Shanghai 200040, Peoples R China
[4] Shanghai Key Lab Med Epigenet, Shanghai 200032, Peoples R China
来源：
ACTA PHARMACEUTICA SINICA B | 2022年 / 12卷 / 07期
关键词：
COVID-19; Human Identical Sequences; Hyaluronan; Hymecromone; Antisense oligonucleotides;
D O I：
10.1016/j.apsb.2022.03.022
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：3195 / 3197
页数：3
相关论文
共 50 条
  • [41] Regulation of miRNA in Cytokine Storm (CS) of COVID-19 and Other Viral Infection: An Exhaustive Review
    Chakraborty, Chiranjib
    Bhattacharya, Manojit
    Das, Arpita
    Saha, Abinit
    REVIEWS IN MEDICAL VIROLOGY, 2025, 35 (02)
  • [42] Viral vector and nucleic acid vaccines against COVID-19: A narrative review
    Khoshnood, Saeed
    Ghanavati, Roya
    Shirani, Maryam
    Ghahramanpour, Hossein
    Sholeh, Mohammad
    Shariati, Aref
    Sadeghifard, Nourkhoda
    Heidary, Mohsen
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [43] Plant metabolites as potential therapeutics against COVID-19 and other viral diseases
    Kayesth, Sunil
    Chaudhary, Ashu
    Shazad, Mohd
    Saini, Priyanka
    Nisspatorn, Veeranoot
    Shah, Vijay Kumar
    Sharma, Chandni
    Sagar, Rohit
    Chaprana, Parveen
    Arora, Jyoti
    Zarubaev, Vladimir V.
    Gupta, Kamal Kumar
    INDIAN JOURNAL OF NATURAL PRODUCTS AND RESOURCES, 2024, 15 (02): : 201 - 223
  • [44] Fighting Fire with Fire: Immunogenicity of Viral Vectored Vaccines against COVID-19
    Chang, Aiquan
    Yu, Jingyou
    VIRUSES-BASEL, 2022, 14 (02):
  • [45] Physical Exercise Potentials Against Viral Diseases Like COVID-19 in the Elderly
    Amatriain-Fernandez, Sandra
    Gronwald, Thomas
    Murillo-Rodriguez, Eric
    Imperatori, Claudio
    Solano, Alexandre Francisco
    Latini, Alexandra
    Budde, Henning
    FRONTIERS IN MEDICINE, 2020, 7
  • [46] Remitting neuropsychiatric symptoms in COVID-19 patients: Viral cause or drug effect?
    Forero-Pena, David A.
    Hernandez, Matthew M.
    Mozo Herrera, Iriana Paola
    Collado Espinal, Ivan Bolivar
    Paez Paz, Joselyn
    Ferro, Carlos
    Flora-Noda, David M.
    Maricuto, Andrea L.
    Velasquez, Viledy L.
    Camejo-Avila, Natasha A.
    Sordillo, Emilia M.
    Delgado-Noguera, Lourdes A.
    Perez-Garcia, Luis A.
    Morantes Rodriguez, Carlos G.
    Eugenia Landaeta, Maria
    Paniz-Mondolfi, Alberto E.
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (03) : 1154 - 1161
  • [47] AI-driven drug discovery: A boon against COVID-19?
    Kaushik, Aman Chandra
    Raj, Utkarsh
    AI OPEN, 2020, 1 : 1 - 4
  • [48] Boosting the arsenal against COVID-19 through computational drug repurposing
    Ciliberto, Gennaro
    Cardone, Luca
    DRUG DISCOVERY TODAY, 2020, 25 (06) : 946 - 948
  • [49] A Comprehensive Review of Drug Repurposing Strategies against Known Drug Targets of COVID-19
    Khataniar, Ankita
    Pathak, Upasana
    Rajkhowa, Sanchaita
    Jha, Anupam Nath
    COVID, 2022, 2 (02): : 148 - 167
  • [50] Amphotericin B as antiviral drug: Possible efficacy against COVID-19
    AL-Khikani, Falah Hasan Obayes
    ANNALS OF THORACIC MEDICINE, 2020, 15 (03) : 118 - 124
12345